Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Cannacore Group Expands Services to Psychedelic Markets in Oregon and Colorado


News provided by

CannaCore Group

May 19, 2023, 08:30 ET

Share this article

Share toX

Share this article

Share toX


Due to the novelty of the psychedelic market, Cannacore Group understands that having an expert Team behind you to overcome the complex regulatory obstacles is essential to ensuring your success. If you are interested in discussing your options, contact our Team today. We look forward to working with you!

MIAMI, May 19, 2023 /PRNewswire-PRWeb/ -- The Magic Mushroom's Continuous Legalization Across the United States

In 2020, Oregon became to first state to legalize psilocybin for therapeutic purposes through [Measure 109, which was approved by a 55.75% majority vote. Due to the passage of the Psilocybin Program Initiative, licensed service providers are allowed to prescribe psilocybin products to patients 21 or older. Under the Oregon Health Authority's framework, there are four (4) types of available licenses: (1) Service Center; (2) Manufacturer; (3) Facilitator; and (4) Psilocybin Testing Laboratory. Per the Oregon Psilocybin Services' spring newsletter, there have been 11 applications submitted for Service Center licenses, 16 applications submitted for Manufacturer license, 27 applications submitted for Facilitator licenses, and 2 applications submitted for Laboratory licenses. Presently, only 2 licenses have been awarded thus far.

With a Team that has over 19+ years of combined knowledge and experience in regulated industries, Cannacore Group brings a unique and innovative perspective to each application as we have worked in various states from vertically integrated systems to individual licensing.

Post this

Two years after the City of Denver decriminalized the use of psilocybin for adults 21 and older, the state of Colorado passed Proposition 122 in 2022 to legalize psychedelics, specifically psilocybin for therapeutic uses in mental healthcare. The appointed Natural Medicine Advisory Board will make its first recommendations by September 30th for regulatory oversight, so clinics can begin offering psilocybin by late 2024. Due to its more expansive legislation, Proposition 122 further allows officials to develop similar programs by 2026 for other psychedelic substances like DMT, ibogaine, and mescaline (excluding peyote).

Although Oregon and Colorado are the only "legalized" markets presently, several other states and cities are beginning to not only decriminalize the use of psilocybin, but also expanding their research initiatives. Washington DC has decriminalized its use, as well as several cities within Michigan, Massachusetts, and Washington. Further, numerous states have either passed or initiated bills to promote research into the medical and potential of psilocybin for a variety of conditions. Such states include: Arizona, Hawaii, Missouri, Montana, New Hampshire, New Jersey, Utah, and more!

Who is Cannacore Group?

Cannacore Group is a team of experts with a passion for building successful businesses specializing in controlled substances from its initial start-up phase to a fully thriving operational business. From assisting our clients in identifying new markets to target to bringing in additional resources such as funding and an operational team from an expansive network, the Cannacore Group team works with clients side-by-side to ensure we can achieve their goals. Through extensive collaboration with clients across the United States, Cannacore Group has successfully supported marijuana businesses in 10+ states and have achieved an overall success rate of ~85%. Due to Cannacore Group's work with legal markets from its initial onset, Cannacore Group has a deep understanding of the array of complex regulations that are key to obtaining a prosperous business license. As such, we are bringing our unique experiences and expert skillset garnered from working in highly regulated industries to the psychedelic markets in Oregon and Colorado to further assist innovative enterprises.

Founder/CEO, Paula Savchenko, Esq., has spent her career tailoring her services to each client's individual needs. From liquor and tobacco licensing to cannabis business licensing, she has led the Cannacore Group in developing proven Standard Operating Procedures to ensure continuous success pre- and post-licensure. With a Team that has over 19+ years of combined knowledge and experience in regulated industries, Cannacore brings a unique and innovative perspective to each application as we have worked in various states from vertically integrated systems to individual licensing. Cannacore Group's goal is to set our clients apart from the rest through strategic partnerships, foundational relationships with local partners and entities, and trailblazing community outreach and development.

How Can CannaCore Group Help You Achieve Your Goals in the Psychedelic Market?

To enter the legal psychedelic market, there are various regulatory requirements that are demanded by the state. Due to the relative similarity of the psychedelic licensing market and cannabis business licensing industry, the Cannacore Group team has an in-depth understanding of how to successfully meet all such requirements to ensure your team creates a strong, trusting relationship with the state's regulatory body. Depending on your team's needs, Cannacore Group offers an array of services to best meet your current and future goals. From building a team, including local partners and organizations, to introducing you to our network of lobbyists and expert industry professionals, we will make sure you have a strong group to enter such competitive markets. Further, Cannacore Group will provide proven Standard Operating Procedures and personalized narratives to ensure we represent your team as an efficient, turnkey group who is eager and ready to enter the industry. Cannacore Group will collaboratively develop innovative strategies to help differentiate your team from the rest through tactical funding, community outreach initiatives, and identifying ideal facilities.

With psilocybin legalization on the rise, Oregon has provided the initial template of what licensing for psychedelic businesses, specifically those still federally classified as a Schedule I drug, will look like. From residency ownership requirements to mandating locality approval, we will help your team overcome any and all regulatory requirements regardless of how each state adapts the process to their specific needs.

Contact Us Today!

Due to the novelty of the psychedelic market, we understand that having an expert Team behind you to overcome the complex regulatory obstacles is essential to ensuring your success. If you are interested in discussing your options, contact our Team today at mailto:[email protected] [[email protected] __title__ null] or via our website: https://www.cannacoregrp.com/contact/

We look forward to working with you!

Media Contact

Paula Savchenko, CannaCore Group, 1 (561) 888-0874, [email protected]

SOURCE CannaCore Group

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.